JWM
ACAD icon

Janiczek Wealth Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Janiczek Wealth Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14
Closed – – 892
2021
Q1 		$0 Sell
14
-247
-95% -$10.9K ﹤0.01% 855
2020
Q4 		$14K Buy
+261
New +$13K 0.01% 400

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Janiczek Wealth Management's ACAD Position: Q2 2021 in Review

Janiczek Wealth Management sold out of Acadia Pharmaceuticals (ACAD) in Q2 2021, closing a stake of 14 shares.

Janiczek Wealth Management first reported a position in ACAD in Q4 2020 and held it in 2 quarters. The position peaked at $14K in Q4 2020. 245 funds tracked by Wall St. Rank hold ACAD as of Q2 2021.

  • Janiczek Wealth Management reported no remaining Acadia Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Janiczek Wealth Management sold 14 Acadia Pharmaceuticals shares in Q2 2021.
  • Janiczek Wealth Management first reported a position in Acadia Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Janiczek Wealth Management's Acadia Pharmaceuticals position peaked at $14K in Q4 2020.
  • 245 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2021.

Based on Janiczek Wealth Management's 13F filing for Q2 2021, filed 28 Jul 2021.